It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 3 FA rating(s) are green whileSAFRF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 3 TA indicator(s) are bullish while SAFRF’s TA Score has 4 bullish TA indicator(s).
AXON (@Aerospace & Defense) experienced а -2.05% price change this week, while SAFRF (@Aerospace & Defense) price change was +1.09% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was -2.03%. For the same industry, the average monthly price growth was +5.12%, and the average quarterly price growth was +26.52%.
AXON is expected to report earnings on Mar 04, 2025.
Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
AXON | SAFRF | AXON / SAFRF | |
Capitalization | 48.2B | 92.4B | 52% |
EBITDA | 408M | N/A | - |
Gain YTD | 144.528 | 25.521 | 566% |
P/E Ratio | 164.08 | 53.91 | 304% |
Revenue | 1.94B | N/A | - |
Total Cash | 1.16B | N/A | - |
Total Debt | 721M | N/A | - |
AXON | SAFRF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 2 | 52 | |
SMR RATING 1..100 | 53 | 97 | |
PRICE GROWTH RATING 1..100 | 2 | 55 | |
P/E GROWTH RATING 1..100 | 30 | 7 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SAFRF's Valuation (54) in the null industry is somewhat better than the same rating for AXON (92) in the Biotechnology industry. This means that SAFRF’s stock grew somewhat faster than AXON’s over the last 12 months.
AXON's Profit vs Risk Rating (2) in the Biotechnology industry is somewhat better than the same rating for SAFRF (52) in the null industry. This means that AXON’s stock grew somewhat faster than SAFRF’s over the last 12 months.
AXON's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for SAFRF (97) in the null industry. This means that AXON’s stock grew somewhat faster than SAFRF’s over the last 12 months.
AXON's Price Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for SAFRF (55) in the null industry. This means that AXON’s stock grew somewhat faster than SAFRF’s over the last 12 months.
SAFRF's P/E Growth Rating (7) in the null industry is in the same range as AXON (30) in the Biotechnology industry. This means that SAFRF’s stock grew similarly to AXON’s over the last 12 months.
AXON | SAFRF | |
---|---|---|
RSI ODDS (%) | 4 days ago64% | N/A |
Stochastic ODDS (%) | 4 days ago85% | 4 days ago74% |
Momentum ODDS (%) | 4 days ago64% | 4 days ago61% |
MACD ODDS (%) | 4 days ago67% | 4 days ago61% |
TrendWeek ODDS (%) | 4 days ago65% | 4 days ago69% |
TrendMonth ODDS (%) | 4 days ago79% | 4 days ago58% |
Advances ODDS (%) | 4 days ago79% | 4 days ago68% |
Declines ODDS (%) | 6 days ago67% | 8 days ago52% |
BollingerBands ODDS (%) | 4 days ago63% | 4 days ago77% |
Aroon ODDS (%) | 4 days ago74% | 4 days ago66% |
A.I.dvisor tells us that AXON and DRS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AXON and DRS's prices will move in lockstep.
Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
---|---|---|---|---|
AXON | 100% | +2.60% | ||
DRS - AXON | 30% Poorly correlated | +3.22% | ||
CMGMF - AXON | 30% Poorly correlated | N/A | ||
KTOS - AXON | 28% Poorly correlated | +1.05% | ||
AIR - AXON | 27% Poorly correlated | -0.05% | ||
CAE - AXON | 27% Poorly correlated | +4.16% | ||
More |
A.I.dvisor tells us that SAFRF and RYCEY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFRF and RYCEY's prices will move in lockstep.
Ticker / NAME | Correlation To SAFRF | 1D Price Change % | ||
---|---|---|---|---|
SAFRF | 100% | +0.22% | ||
RYCEY - SAFRF | 30% Poorly correlated | +0.14% | ||
MTUAY - SAFRF | 30% Poorly correlated | +0.23% | ||
SAFRY - SAFRF | 28% Poorly correlated | +0.31% | ||
MTUAF - SAFRF | 22% Poorly correlated | -3.28% | ||
AXON - SAFRF | 21% Poorly correlated | +2.60% | ||
More |